Literature DB >> 2530749

Non-Hodgkin's lymphoma involving the brain. Diagnostic usefulness of stereotactic needle biopsy in combination with paraffin-section immunohistochemistry.

H Nakamine1, H Yokote, T Itakura, S Hayashi, N Komai, Y Takano, K Saito, H Moriwaki, E Nishino, T Takenaka.   

Abstract

A stereotactic needle biopsy was examined for applicability in diagnosing brain non-Hodgkin's lymphoma (NHL), because the procedure is far less aggressive than biopsy by open surgery. Formalin-fixed materials including four stereotactic specimens were available from nine patients with brain NHL. In addition to routine histopathology and histochemistry, paraffin-section immunohistochemistry was performed using a panel of monoclonal antibodies suited to such sections. Although several histopathological features characteristic of brain NHL could not be evaluated in three of the four stereotactic specimens owing to the small size of the specimens and partial invasion by lymphoma cells, the lesions in all cases could be characterised by immunohistochemistry. Examination for cytoplasmic immunoglobulin (cIg) was also performed, but specific identification of cIg was difficult in five cases because of diffuse background staining and passive diffusion of plasma protein into the cells during tissue processing. A review of the literature indicates the technical difficulty in cIg staining, since the incidence of cIg-positive cases in an individual study varied considerably, and lymphoma cells in 15 of 128 cIg-positive brain NHL cases have been reported to possess both light chains. From these findings, together with the relative difficulty in obtaining fresh tissues for study, it is concluded that, when the specimens are to be examined by paraffin-section immunohistochemistry using the above monoclonal antibodies, stereotactic needle biopsy is a useful, less aggressive method for diagnosing brain NHL.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2530749     DOI: 10.1007/bf00687707

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  59 in total

1.  The demonstration of B-cell, T-cell and myeloid antigens in paraffin sections.

Authors:  K P West; A Warford; L Fray; M Allen; A C Campbell; I Lauder
Journal:  J Pathol       Date:  1986-10       Impact factor: 7.996

2.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

3.  Monoclonal antibody L26: an antibody that is reactive with normal and neoplastic B lymphocytes in routinely fixed and paraffin wax embedded tissues.

Authors:  A J Norton; P G Isaacson
Journal:  J Clin Pathol       Date:  1987-12       Impact factor: 3.411

4.  A monoclonal antibody (MMA) that identifies a differentiation antigen on human myelomonocytic cells.

Authors:  S N Hanjan; J F Kearney; M D Cooper
Journal:  Clin Immunol Immunopathol       Date:  1982-05

5.  [Primary brain lymphomas. Anatomoclinical, ultrastructural and immunocytochemical study about 23 cases (author's transl)].

Authors:  J Hassoun; L Andrac; D Gambarelli; M Toga
Journal:  Ann Pathol       Date:  1981       Impact factor: 0.407

6.  Cell surface markers for diagnosis of central nervous system involvement in lymphoproliferative diseases.

Authors:  J Ernerudh; T Olsson; G Berlin; B Gustafsson; H Karlsson
Journal:  Ann Neurol       Date:  1986-11       Impact factor: 10.422

7.  Immunohistochemical localization of neuron-specific enolase in the human hypophysis and pituitary adenomas.

Authors:  S L Asa; N Ryan; K Kovacs; W Singer; P J Marangos
Journal:  Arch Pathol Lab Med       Date:  1984-01       Impact factor: 5.534

8.  Primary lymphoma of the central nervous system. Clinicopathological study of experience at Stanford.

Authors:  T L Helle; R H Britt; T V Colby
Journal:  J Neurosurg       Date:  1984-01       Impact factor: 5.115

9.  Primary lymphoma of the central nervous system.

Authors:  L Letendre; P M Banks; D F Reese; R H Miller; P W Scanlon; J M Kiely
Journal:  Cancer       Date:  1982-03-01       Impact factor: 6.860

10.  [Primary non-Hodgkin's malignant lymphomas of the brain. Anatomoclinical and immunopathological study of 21 cases].

Authors:  A de Mascarel; C Vital; J Rivel; C Deminiere; M Trojani; I de Mascarel; S Sakiri
Journal:  Sem Hop       Date:  1983-01-20
View more
  5 in total

Review 1.  Primary cerebral malignant non-Hodgkin's lymphomas: a retrospective clinical study.

Authors:  D F Braus; K Schwechheimer; H K Müller-Hermelink; G Schwarzkopf; B Volk; F Mundinger
Journal:  J Neurol       Date:  1992-03       Impact factor: 4.849

2.  Hemagglutination and graft-versus-host disease in the severe combined immunodeficiency mouse lymphoproliferative disease model.

Authors:  S J Pirruccello; H Nakamine; K W Beisel; K L Kleveland; M Okano; Y Taguchi; J R Davis; M L Mahloch; D T Purtilo
Journal:  Am J Pathol       Date:  1992-05       Impact factor: 4.307

3.  Diagnosis of primary cerebral lymphoma with particular reference to CT-guided stereotactic biopsy.

Authors:  W Feiden; K Bise; U Steude
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

4.  Glucocorticoid therapy obscures the diagnosis of cerebral lymphoma.

Authors:  M Geppert; C B Ostertag; G Seitz; M Kiessling
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

Review 5.  Primary central nervous system lymphomas--an update.

Authors:  K A Jellinger; W Paulus
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.